openPR Logo
Press release

MRRSE | Current Market Scenario of Pharmacovigilance and Drug Safety Software Industry |Key Players - UMBRA Global LLC, AB Cube, United BioSource Corporation, Sparta Systems, Inc., Oracle Corporation, EXTEDO GmbH, Ennov Solutions, Inc., and ArisGlobal

01-23-2019 11:44 AM CET | Industry, Real Estate & Construction

Press release from: MRRSE PVT LTD

MRRSE

MRRSE

Market Research Reports Search Engine (MRRSE) has been acting as an impressive data source when it comes to evaluating various industrial verticals. The research report titled “Pharmacovigilance and Drug Safety Software Market“Offers a clear insight about the "Telecommunication" assessed over the global platform. This analysis proves beneficial for readers & new investors who are aiming to enter the market for "Telecommunication" in the near future.

For In-depth Research Study _ Get Report Sample Copy @ https://www.mrrse.com/sample/1472

The global pharmacovigilance and drug safety software market is envisioned to attract benefits while riding on the ability of products to avert, evaluate, and uncover enduring and temporary side effects of certain medications. Pharmacovigilance software could help to inhibit unnecessary future events and determine the cause of withdrawal. These software could be of great use to all those concerned with the medical process, such as drug consumers, prescribers, and manufacturers. Companies are prominently enabled to put into practice proactive safety surveillance programs with the support provided by pharmacovigilance software as they push new limits in the market.

The world pharmacovigilance and drug safety software market is expected to embrace favorable opportunities on the back of government policies related to drug safety regulations and rising rates of cases that pertain to adverse drug reaction. The market could also gain impetus from the surging need for new drug development, considering the high prevalence of chronic ailments and growing geriatric population. Pharmacovigilance software could find an application to minimize the limitations faced by small organizations relating to personnel and financial resources.

More prospects are projected to take birth in the world pharmacovigilance and drug safety software market with mounting private and public investments in pharmaceutical research and development activities. The high growth rate of pharmaceutical companies conducting research outsourcing could augur well for the rise in the demand for pharmacovigilance and drug safety software.

Browse Complete Research Report with TOC @ https://www.mrrse.com/pharmacovigilance-drug-safety-software-market

The international pharmacovigilance and drug safety software market is predicted to be classified into adverse event reporting software, drug safety audits software, issue tracking software, and fully integrated software as per segmentation by type of software. With a 39.7% share achieved in 2017, adverse event reporting software could rake in a greater revenue in the market by the end of 2022.

In terms of end user, the international pharmacovigilance and drug safety software market is predicted to be segregated into pharma and biotech companies, contract research organizations (CROs), business process outsourcing (BPO) firms, and other pharmacovigilance service providers.

On the basis of delivery mode, there could be prospects birthing in the international pharmacovigilance and drug safety software market from vital segments such as on-premise delivery mode and cloud-based delivery mode.

In respect of regional segmentation, the international pharmacovigilance and drug safety software market is anticipated to be divided into Latin America, the Middle East and Africa (MEA), North America, Asia Pacific except Japan (APEJ), and Europe. Among key countries, Japan could expand at a slightly better CAGR of 3.9% than that of the MEA. However, North America is prognosticated to lead the market after earning a US$58.5 mn in 2017.

The worldwide pharmacovigilance and drug safety software market is envisaged to witness the presence of significant companies such as UMBRA Global LLC, AB Cube, United BioSource Corporation, Sparta Systems, Inc., Oracle Corporation, EXTEDO GmbH, Ennov Solutions, Inc., and ArisGlobal.

Enquire About This Report @ https://www.mrrse.com/enquiry/3694

About MRRSE

Market Research Reports Search Engine (MRRSE) is an industry-leading database of Market Research Reports. MRRSE is driven by a stellar team of research experts and advisors trained to offer objective advice. Our sophisticated search algorithm returns results based on the report title, geographical region, publisher, or other keywords.

MRRSE partners exclusively with leading global publishers to provide clients single-point access to top-of-the-line market research. MRRSE’s repository is updated every day to keep its clients ahead of the next new trend in market research, be it competitive intelligence, product or service trends or strategic consulting.

Contact Us

State Tower
90, State Street
Suite 700
Albany, NY – 12207(United State)
United States Telephone: +1-518-730-0559(Toll-Free)
Email: sales@mrrse.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release MRRSE | Current Market Scenario of Pharmacovigilance and Drug Safety Software Industry |Key Players - UMBRA Global LLC, AB Cube, United BioSource Corporation, Sparta Systems, Inc., Oracle Corporation, EXTEDO GmbH, Ennov Solutions, Inc., and ArisGlobal here

News-ID: 1525144 • Views:

More Releases from MRRSE PVT LTD

Wire and Cable Market Projected to reach US$ 235.9 Bn by 2026 | Key Players - Hengtong Optic-Electric Co Ltd., Furukawa Electric Co., Ltd., Sumitomo Electric Industries, Ltd., General Cable Corporation
Wire and Cable Market Projected to reach US$ 235.9 Bn by 2026 | Key Players - He …
This comprehensive report by MRRSE analyzes and forecasts the wire and cable market at the global and regional level. The report provides an analysis over the period 2018–2026, wherein 2018 to 2026 is the forecast period and the base year is 2017. An in-depth and unbiased market assessment has been made to offer readers in-depth and accurate analysis. The report emphasizes on all the major trends and services playing a
RFID Tags Market Insights Covering Market Dynamics and Competitive Scenario through 2025
RFID Tags Market Insights Covering Market Dynamics and Competitive Scenario thro …
A new report on RFID tags delivers in-depth understanding on the consecutive growth path of the market along with the future scenarios and present situation of the market. The report offers an exclusive analysis of the global market and also presents insights on regional and other important segments. Get Report Sample Copy @ https://www.mrrse.com/sample/4726 The report offers a summary of the global market including an official abstract that draws out the core
Security and Vulnerability Management Market Analysis Covering Size, Share, Growth, Trends and Upcoming Opportunities
Security and Vulnerability Management Market Analysis Covering Size, Share, Grow …
The global security and vulnerability management market is expected to witness significant growth during the forecast period. This growth is attributed to the increasing usage of cloud-based solutions and services, and the growing demand for security and vulnerability management solutions in the BFSI and healthcare sectors. North America is expected to be the dominant region in 2017 in terms of value in the security and vulnerability management market. In the
Power Management Integrated Circuit (PMIC) Market to hit US$ 56.48 Bn by 2026
Power Management Integrated Circuit (PMIC) Market to hit US$ 56.48 Bn by 2026
In the present times, there is an increasing demand for IoT and power optimization solutions, due to which smart grids, energy storage systems and electric cars are becoming popular all over the world. This situation creates a huge opportunity for power management integrated circuit manufacturers. With the help of power management integrated circuits, the usage of power sources across various industrial applications can be optimized. Hence, it is estimated that

All 5 Releases


More Releases for Pharmacovigilance

Top Pharmacovigilance Companies Analysis By 2031
The Pharmacovigilance Market is expected to register a CAGR of 6.6% from 2025 to 2031, with a market size expanding from US$ XX million in 2024 to US$ XX Million by 2031. Download PDF Copy @ https://www.theinsightpartners.com/sample/TIPRE00003127?utm_source=OpenPR&utm_medium=10379 The List of Companies • #Accentures • Bristol-Myers Squibb Company • Linical Accelovance • Cognizant • Covance Inc. • F. Hoffmann-La Roche Ltd. • GlaxoSmithKline plc. • ICON plc • Capgemini (IGATE Corporation) Clinical
Pharmacovigilance - Scope and Research Methodology
The Pharmacovigilance Market is expected to register a CAGR of 6.6% from 2025 to 2031, with a market size expanding from US$ XX million in 2024 to US$ XX Million by 2031. The Pharmacovigilance Market report covers analysis by Clinical Trial Phase (Pre-Clinical, Phase I, Phase II, Phase III, and Phase IV), Service Provider (In-House and Contract Outsourcing), Type of Method (Spontaneous Reporting, Intensified ADR Reporting, Targeted Spontaneous Reporting, Cohort Event
Pharmacovigilance World 2025 Conference & Expo
We are delighted to welcome you to the Pharmacovigilance World 2025, and we are confident that your active participation will contribute to the advancement of drug safety practices. Together, let us strive towards a safer and more vigilant healthcare system that prioritizes patient well-being and ensures the continued benefit of medications worldwide. As medical science advances, so does our understanding of drug safety and the need for vigilance when it comes
Top Factor Driving Pharmacovigilance Market Growth in 2025: Research And Develop …
How Are the key drivers contributing to the expansion of the pharmacovigilance market? The escalation in research and development undertakings stimulates growth in the pharmacovigilance market. Pharmaceutical organizations can create novel and superior drugs through enhanced safety profiles by allocating resources to R&D. The intensive testing in preclinical and clinical stages during the drug development protocol allows early recognition of potential safety issues, paving the way for adequate risk reduction approaches.
Monitoring Medication Safety with Pharmacovigilance
Pharmacovigilance (PV) is defined as the science and activities relating to the detection, assessment, understanding and prevention of adverse effects or any other drug-related problem. Pharmacovigilance plays a significant role in pharmaceutical and biotechnological sectors in designing of drugs and their interactions. The pharmacovigilance involves collecting information from healthcare providers and patients to know about the hazards associated with medications. Download Sample PDF at: https://www.theinsightpartners.com/sample/TIPRE00003127?utm_source=OpnePR&utm_medium=10776 Increasing cases of adverse drug reactions
Pharmacovigilance Market Opportunity Analysis by 2028
Pharmacovigilance Market: Introduction According to the report, the global pharmacovigilance market was valued at US$ 6.1 Bn in 2020 and is projected to expand at a CAGR of 8.8% from 2021 to 2028. Pharmacovigilance activities are defined as science used for detection, assessment, understanding, and prevention of adverse effects of drugs and vaccines. Drugs and vaccines go through rigorous testing in the clinical trials to check their safety and efficacy before